Clinical Trial Update: Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant SEEOX chemotherapy for Borrmann Type 4 gastric cancer; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Epirubicin (epirubicin)
• Etoposide (Etoposide)
• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Jinling Hospital, China | Conditions: Stomach Neoplasms, Gastric Cancer | Phase 2 | Status: UNKNOWN